A prospective study of a quantitative PCR ELISA assay for the diagnosis of CMV pneumonia in lung and heart-transplant recipients

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Volumn 19, Issue 8, 2000, Pages 771-780

  Barber, Lisa ^a   Egan, Jim J ^b   Lomax, Joyce ^a   Haider, Yussef ^b   Yonan, Nizar ^c   Woodcock, Ashley A ^b   Turner, Andrew J ^a   Fox, Andrew J ^a  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b North West Lung Centre   (United Kingdom)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN; VIRUS DNA;

ARTICLE; BLOOD; COHORT ANALYSIS; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART LUNG TRANSPLANTATION; HUMAN; ISOLATION AND PURIFICATION; LUNG TRANSPLANTATION; METHODOLOGY; MICROBIOLOGY; NEUTROPHIL; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; VIRUS PNEUMONIA;

ANTIGENS, VIRAL; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART-LUNG TRANSPLANTATION; HUMANS; LUNG TRANSPLANTATION; NEUTROPHILS; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 0034241913     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00136-4     Document Type: Article

References (28)

1. S Noble D Faulds Ganciclovir an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients Drugs 56 1 1998 115 146
2. J Egan J Lomax L Barber Pre-emptive treatment for the prevention of CMV disease Transplantation 15 1998 747 752
3. A Erice S Chou K.K Biron Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients N Engl J Med 320 1989 289 293
4. W.L Drew R.C Miner D.F Busch Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection J Infect Dis 163 1991 716 719
5. R.H Rubin Preemptive therapy in immunocompromised hosts N Engl J Med 324 1991 1057 1059
6. R.L Saltzman M.R Quirk M.C Jordan High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients J Clin Invest 90 1992 1832 1838
7. G Gerna D Zipeto M Parea Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAaemia J Infect Dis 164 1991 488 498
8. J.J Egan L Barber J Lomax Detection of human cytomegalovirus antigenaemia a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients Thorax 50 1995 9 13
9. R.D Allen P.E Pellet J.A Stewart Non-radioactive PCR-enzyme-linked immunosorbent assay method for detection of human cytomegalovirus DNA J Clin Microbiol 33 3 1995 725 728
10. P Friedhoff M Hahn H Wolfes Quantitative PCR with oligodeoxynucleotide ligation assay/enzyme-linked immunosorbent assay detection Anal Biochem 215 1 1993 9 16
11. A Ferreira-Gonzalez R.A Fisher L.A Weymouth Clinical utility of a quantitative polymerase chain reaction for diagnosis of cytomegalovirus disease in solid organ transplant patients Transplantation 68 7 1999 991 996
12. L Barber J.J Egan J Lomax Comparative study of three PCR assays with antigenaemia and serology for the diagnosis of HCMV infection in thoracic transplant recipients J Med Virology 49 1996 137 144
13. D.J Morris J Lomax J Craske Effects of centrifugal enhancement of infectivity on the rapid detection of human cytomegalovirus in cell culture by immunofluorescence using a monoclonal antibody to immediate early nuclear antigen Serodiagn Immunother Infect Dis 1 1987 141 152
14. D.J Morris A.J Fox P.C.A Grint Cytomegalovirus, varicella zoster and coxsackie B virus specific IgM antibody response in children with cancer Serodiagn Immunother Infect Dis 4 1990 115 120
15. J Darlington M Super K Patel Use of the polymerase chain reaction to analyse sequence variation within a major neutralising epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus J Gen Virol 72 1991 1985 1989
16. T.J Vecchio Predicted value of a single diagnostic test in unselected population N Engl J Med 274 1966 1171 1173
17. M Boeckh P.M Woogerd T Stevens-Ayers Factors influencing detection of quantitative cytomegalovirus antigenaemia J Clin Microbiol 32 1994 832 834
18. P Schäfer W Tenschert K Gutensohn Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of an antigenemia assay J Clin Microbiol 35 1997 741 744
19. Barber L, Egan JJ, Turner AJ, et al. The development of a quantitative PCR ELISA to determine HCMV DNAemia levels in heart, heart lung and lung transplant recipients. J Virol Methods 1999 (in press).
20. A Zeevi P Morel K Spichty Clinical significance of CMV-specific T-helper responses in lung transplant patients Hum Immunol 59 12 1998 768 775
21. A.T Kotsimbos V Sinickas E.M Glare Quantitative detection of human cytomegalovirus DNA in lung transplant recipients Am J Respir Crit Care Med 156 4 pt.1 1997 1241 1260
22. D Zipeto M.G Revello E Silini Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients J Clin Microbiol 30 1992 527 530
23. P.T Cagle G Buffone V.A Holland Semi-quantitative measurement of cytomegalovirus DNA in lung and heart transplant patients by in vitro DNA amplification Chest 101 1992 93 96
24. W.T Lee H Antoszewska K.F Powell Polymerase chain reaction in detection of CMV DNA in renal allograft recipients Aust N Z Med 22 1992 249 255
25. H.A Bassler S.J.A Flood K.J Livak Use of a fluorogenic probe in a PCR-based assay for the detection of Listeria monocytogenes Appl Environ Microbiol 61 1995 3724 3727
26. K.J Livak S.J Flood J Marmaro Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridisation PCR Methods Appl 4 1995 357 362
27. C.S Marti L Butler I Bronstein Quantitation of PCR products with chemiluminescence Biotechniques 18 5 1995 908 910
28. Aitken C, Barrett-Muir W, Millar C, et al. Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation. J Clin Microbiol 1999;37(9):2804–7.